Purification of human serum paraoxonase/arylesterase. Evidence for one esterase catalyzing both activities
- PMID: 1673382
Purification of human serum paraoxonase/arylesterase. Evidence for one esterase catalyzing both activities
Abstract
Evidence is presented that human serum contains a single enzyme with both paraoxonase and arylesterase activities. Throughout the steps of purification and after obtaining over 600-fold purification of the enzyme, the arylesterase activity (measured with phenylacetate as the substrate) co-eluted and retained the same ratio of activity to paraoxonase activity as it had in the initial plasma sample. Paraoxon and DFP (diisopropylfluorophosphate) both complete with phenylacetate as substrates; the inhibition is of mixed type with paraoxon and competitive with DFP. Paraoxonase and arylesterase activities require calcium, and both are inhibited to the same degree by EDTA. Purified arylesterase/paraoxonase is a glycoprotein with a minimal molecular weight of about 43,000. It has up to three sugar chains per molecule, and carbohydrate represents about 15.8% of the total weight. The enzyme has an isoelectric point of 5.1. Its amino acid composition shows nothing unusual, except for a relatively high content of leucine. We conclude that human serum arylesterase and paraoxonase activities are catalyzed by a single enzyme, capable of hydrolyzing a broad spectrum of organophosphate substrates and a number of aromatic carboxylic acid esters. Studies on the genetically determined polymorphism responsible for two allozymic forms (A and B) of the esterase are described in the following paper.
Similar articles
-
Identification of two rat liver proteins with paraoxonase activity: biochemical evidence for the identity of paraoxonase and arylesterase.Chem Biol Interact. 1999 May 14;119-120:263-75. doi: 10.1016/s0009-2797(99)00036-8. Chem Biol Interact. 1999. PMID: 10421461
-
Studies on human serum paraoxonase/arylesterase.Chem Biol Interact. 1993 Jun;87(1-3):25-34. doi: 10.1016/0009-2797(93)90022-q. Chem Biol Interact. 1993. PMID: 8393742
-
The polymorphic paraoxonase/arylesterase isozymes of human serum.Fed Proc. 1984 May 15;43(8):2338-41. Fed Proc. 1984. PMID: 6325253
-
The human serum paraoxonase/arylesterase polymorphism.Am J Hum Genet. 1983 Nov;35(6):1126-38. Am J Hum Genet. 1983. PMID: 6316781 Free PMC article.
-
Characteristics of the genetically determined allozymic forms of human serum paraoxonase/arylesterase.Drug Metab Dispos. 1991 Jan-Feb;19(1):107-12. Drug Metab Dispos. 1991. PMID: 1673383
Cited by
-
Lutein and Zeaxanthin Enhance, Whereas Oxidation, Fructosylation, and Low pH Damage High-Density Lipoprotein Biological Functionality.Antioxidants (Basel). 2024 May 18;13(5):616. doi: 10.3390/antiox13050616. Antioxidants (Basel). 2024. PMID: 38790721 Free PMC article.
-
The Interplay of Dyslipidemia, Oxidative Stress, and Clinical Outcomes in Acute Ischemic Stroke Patients with and without Coronary Artery Disease.Biomedicines. 2024 Feb 1;12(2):332. doi: 10.3390/biomedicines12020332. Biomedicines. 2024. PMID: 38397934 Free PMC article.
-
Grape seed extract prevents chlorpyrifos-induced toxicity in rat liver through the modulation of phase I detoxification pathway.Environ Sci Pollut Res Int. 2024 Mar;31(12):18566-18578. doi: 10.1007/s11356-024-32201-8. Epub 2024 Feb 13. Environ Sci Pollut Res Int. 2024. PMID: 38349500
-
Liver Fat Storage Is a Better Predictor of Coronary Artery Disease than Visceral Fat.Metabolites. 2023 Jul 28;13(8):896. doi: 10.3390/metabo13080896. Metabolites. 2023. PMID: 37623840 Free PMC article.
-
Effect of Exercise Repetitions on Arylesterase Activity of PON1 in Plasma of Average-Trained Men-The Dissociation between Activity and Concentration.Antioxidants (Basel). 2023 Jun 17;12(6):1296. doi: 10.3390/antiox12061296. Antioxidants (Basel). 2023. PMID: 37372026 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases